Investment Q&A

Q: Following the news release from Moderna regarding their interim analysis of their Covid vaccine what is your opinion of this stock going forward?
Geoff

Q: I have noticed a lot of insider selling lately and wonder whether these actions should raise concern. I note your previous response about individuals, even insiders, wanting to use some of the profits or rebalance their investment portfolio(among a couple of good reasons), but when four individuals in the same company start cashing in, should we, the ordinary investor be concerned. What is your current position on these names?- hold or adjust?

Thank you

Peter

Q: I've learned recently that mRNA-based vaccines require extra cold storage (-70C; dry ice temperature). This will be a logistical challenge if such vaccines are approved. Two-part question:

1. Your thoughts on the impact of this logistical challenge on PFE/BNTX and MRNA?

2. Dry ice (solid CO2) lasts only about 3 days in insulated packages. Widespread mRNA vaccine distribution might depend on having a lot more dry ice produced at facilities near airports, shipping hubs, and smaller distribution centers. Any ideas for a play on dry ice via companies selling dry ice production equipment?

Many thanks! New subscriber this year and very satisfied!

Q: Sorry if this is a repeat question. Who do you like as an investment for coming up with a covid vaccine.

Thanks Steve

Q: Hello 5I:
With the big push in the USA for a vaccine for Covid-19 and supporting some companies with funding for research, which would you purchase and why for a speculative purchase....Moderna, Novavax or both. Thanks for your great advice.

Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine

Q: Do you have a number as to what the vaccine revenue might be for COVID 19 ?
It looks like perhaps 50 or more will be splitting the pie, yet a lot of money for all I think.
I am tracking NVAX, SRNE, MRNA.
All are up astronomically, but perhaps will double
Or more from here. Do you guys own any ?
Is there an ETF that holds these vaccine company’s?
Would you buy any, if so which one or one’s ?
I see SRNE is up 26% in the first 8 minutes this morning.
Thanks

Q: Moderna seems interesting for all the wrong reasons. I know they are promotional as you like to put it, but they don't seem to have a single product yet, indeed nothing is even at the clinical testing phase. Their minimal income I presume is from some deals with larger companies and/or simply interest from their cash horde. Do you know of anyone in the leadership with a dubious past or any other reason to suspect out and out malfeasance?

Q: Can you recommend a good ETF probably US based, which has companies in the forefront of corona vaccine development/demonstration, as well as corona related testing and diagnosis.

Q: I have a hefty loss on IIF held in a cash account, I am thinking of selling it to harvest the loss and use part of it to add to a small position of MRNA and/or some other health related stock that may benefit from work on COVID-19 vaccine that you may suggest.
Thank you.

Q: Hi folks,
In view of the coronavirus concerns, which are the companies you would recommend now as likely to grow strongly in the search for a vaccine or in the production of the equipment needed for fighting the spread of this virus ? Could you as well indicate the degree of risk involved in such companies and an order of priorities for the most interesting now ? As a start, what about GILD, INO, MRNA, REGN, SNY ?

Please deduct as many credits as you see fit.

And make sure you stay healthy…...we need you more than ever !

J. IDS

Q: Hi 5i team,

There is no much working in the market these days, which I guess is an understatement. Two stocks that are positively correlated with the virus are MRNA and GILD. There is only one dated question on MRNA. It is developing a potential vaccine for the disease. There is a recent question on GILD, but you did not mention the potential of the drug it is developing to treat people with the disease, likely due to how the question was posed. Both companies are fast-tracking their efforts. MRNA seems to have gone parabolic and hence, looks a lot more risky here. GILD was a value trap for years with a poor pipeline but seems to be breaking out now, which I attribute to the potential of the new drug, if it works.

What are your thoughts on MRNA and GILD is view of their efforts to combat the coronavirus?

Thanks again.
Dave

Q: Moderna stock has been on an uptrend, (depends for how much longer). It has been a profitable investment. What about Difusion Pharmaceuticals? Medical trials seem to show positive results.